Table 1.

BC Cancer Agency (BCCA) treatment protocols

BCCA treatment protocols for no macroscopic residuum ovarian cancers
Date initiated	Risk groups
	Moderate	High
	Stage I, grade 2; stage IIa, grade 1 or 2	Stage I and IIa, grade 3; stage III, any grade
1984	Cisplatin × 3, followed by radiotherapy	Cisplatin/cyclophosphamide × 3, then radiotherapy, followed by cisplatin/cyclophosphamide × 3
1989		Cisplatin × 6
1994	Cisplatin/etoposide × 3, followed by radiotherapy or default to carboplatin × 6
1999	Carboplatin/paclitaxel × 3, followed by radiotherapy or default to carboplatin/paclitaxel × 6 or default to carboplatin × 6

^aIf sharp dissection was used to remove the tumor, BCCA assigned a minimal stage of IIb [13].